Home > PS Ratio > LINCOLN PHARMACEUTICALS

LINCOLN PHARMACEUTICALS
PS (Price/Sales) Ratio

The Current P/S Ratio of LINCOLN PHARMACEUTICALS is 2.63.

Share Price ₹784.9Dec 26,2024
Market Cap ₹1,569.8 Cr
Sales-TTM₹597.4 CrTTM-Consolidated Results
Price/Sales2.63xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for LINCOLN PHARMACEUTICALS
Please provide your vote to see the results
LINCOLN PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best 1M Momentum Small Cap Stocks

Definition & Calculation of PS (Price/Sales) ratio of LINCOLN PHARMACEUTICALS

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of LINCOLN PHARMACEUTICALS is calculated as :

Current Market Cap [ ₹1,569.8 Cr] as on Dec 26,2024

(/) Sales [ ₹597.4 Cr] based on TTM-Consolidated Results

(=) P/S Ratio [ 2.63x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for LINCOLN PHARMACEUTICALS , the investors are currently willing to pay '2.63 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of LINCOLN PHARMACEUTICALS !

The chart below summarizes the trend in P/S Ratio of LINCOLN PHARMACEUTICALS over the last five years.

Historical PS (Price/Sales) ratio chart of LINCOLN PHARMACEUTICALS


PS Ratio Performance Analysis for LINCOLN PHARMACEUTICALS

- LINCOLN PHARMACEUTICALS 's latest p/e ratio is 2.63x.

- LINCOLN PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 1.28x.

- LINCOLN PHARMACEUTICALS 's operated at median p/e ratio of 1.32x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, LINCOLN PHARMACEUTICALS 's p/e ratio peaked in Mar2024 at 2.02x.

- LINCOLN PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2020 of 0.69x.


How does LINCOLN PHARMACEUTICALS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Sales (Cr)PS RatioMarket Cap (Cr)
LINCOLN PHARMACEUTICALS 597.42.631,569.8
SUN PHARMACEUTICAL INDUSTRIES LTD50,307.78.78441,838.0
CIPLA LTD26,512.04.54120,270.0
DR REDDYS LABORATORIES LTD30,084.93.76113,077.0
ZYDUS LIFESCIENCES LTD21,483.54.4996,553.2
DIVIS LABORATORIES LTD8,614.018.12156,107.0
MANKIND PHARMA LTD11,018.010.91120,212.0
TORRENT PHARMACEUTICALS LTD11,225.010.30115,643.0
LUPIN LTD21,431.34.6499,532.1
AUROBINDO PHARMA LTD30,295.02.4172,945.8
ABBOTT INDIA LTD6,066.110.0360,844.2

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs LINCOLN PHARMACEUTICALS 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 2.41x
Max industry PS 18.12x
Median industry PS 4.64x
Average industry PS 7.33x



You may also like the below Video Courses